A comparison of lung cancer in HIV-positive and HIV-negative populations
No Thumbnail Available
Date
2020
Authors
Berman, Ryan
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Background: Lung cancer is the most common cancer worldwide and is the greatest
contributor to malignancy associated deaths. Human Immunodeficiency Virus (HIV) is an
epidemic in many developing countries and South Africa carries the largest burden of disease
in the world. With the introduction of antiretroviral therapy (ART), Acquired Immune
Deficiency Syndrome (AIDS) defining malignancies (ADM’s) are on the decline and non
AIDS defining malignancies (NADM’s) are becoming more common with lung cancer being
the commonest amongst these.
Aim: To describe a cohort of HIV-positive lung cancer patients and a cohort of HIV-negative
lung cancer patients and compare the similarities and differences between the two groups.
Methods: A retrospective study of 188 patients with histologically confirmed bronchogenic
carcinoma was conducted. Smoking history, cancer sub-type, cancer stage, HIV parameters,
and demographic data were collected.
Results: There were 31 (16.94%) HIV-positive patients. They presented at a younger age
(53.94 years) than the HIV-negative group (61.64 years) (p = 0.0001). Adenocarcinoma was
the commonest sub-type in the HIV-negative cohort while squamous cell carcinoma was
slightly more common in the HIV-positive cohort. Both groups predominantly presented with
locally advanced or metastatic disease.
Conclusion: HIV-positive patients present at a younger age than HIV-negative patients and
both groups show a male predominant pattern. We were unable to assess whether smoking
was more common in either group or whether HIV-positive patients present at a more
advanced stage than HIV-negative patients due to a paucity of data.
Description
A research report submitted in partial fulfilment of the requirements for the degree of Master of Medicine to the Faculty of Health Science, University of the Witwatersrand, Johannesburg, 2020